Role of Nitric Oxide Synthase Uncoupling at Rostral Ventrolateral Medulla in Redox-Sensitive Hypertension Associated With Metabolic Syndrome
Kay L.H. Wu, Yung-Mei Chao, Shiow-Jen Tsay, Chen Hsiu Chen, Samuel H.H. Chan, Ima Dovinova, Julie Y.H. Chan
Metabolic syndrome (MetS) is known to be associated with hypertension and recently with oxidative stress. Of note is that oxidative stress in the rostral ventrolateral medulla (RVLM), where sympathetic premotor neurons reside, contributes to sympathoexcitation and hypertension.
The aim of the present study is to identify the source of tissue oxidative stress in RVLM and their roles in neural mechanism of hypertension associated with MetS.
Adult normotensive rats subjected to a high-fructose diet for 8 weeks developed metabolic traits of MetS, alongside increases in sympathetic vasomotor activity and blood pressure.
In RVLM of these MetS rats, the tissue level of reactive oxygen species was increased, nitric oxide (NO) was decreased, and mitochondrial electron transport capacity was reduced. Whereas the protein expression of neuronal NO synthase (nNOS) or protein inhibitor of nNOS was increased, the ratio of nNOS dimer/monomer was significantly decreased.
Oral intake of pioglitazone or intracisternal infusion of tempol or coenzyme Q10 significantly nullified all those molecular events in high-fructose diet–fed rats and increased sympathoexcitation and hypertension.
Gene silencing using lentivirus carrying small hairpin RNA of protein inhibitor of nNOS mRNA in RVLM inhibited protein inhibitor of nNOS expression, increased the ratio of nNOS dimer/monomer, restored NO content, and alleviated oxidative stress in RVLM of high-fructose diet–fed rats.
This also significantly reduced sympathoexcitation and hypertension. These results suggest that redoxsensitive and protein inhibitor of nNOS–mediated nNOS uncoupling is responsible for sustained production of reactive oxygen species in RVLM, resulting in sympathoexcitation and hypertension associated with MetS.
Mahesh Kumar Sivasubramanian
Source: https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.114.03777










